Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vitamin Therapy Cost-Effective In Treating Macular Degeneration – Study

This article was originally published in The Tan Sheet

Executive Summary

Vitamin therapy is a cost-effective approach to lowering the risk of visual impairment in patients diagnosed with age-related macular degeneration, according to a study recently published in the American Academy of Ophthalmology

You may also be interested in...


Nearly 100 centers working on an NIH study on the effects of antioxidants and fish oil on progression of age-related macular degeneration seek 4,000 people ages 50 to 85 with AMD to participate, according to an Oct. 12 announcement. The National Eye Institute, which says nearly 2 mil. people in the U.S. suffer from vision loss due to advanced AMD and 7 mil. with AMD are at "substantial risk," expects the Age-Related Eye Disease Study 2 (AREDS2) to build upon results from the first AREDS data released in 2001 (1"The Tan Sheet" Oct. 15, 2001, p. 3). Those results showed high-dose antioxidant vitamins and minerals (vitamins C and E, beta-carotene, zinc, and copper) reduced the risk of progression to advanced AMD by 25%, and the risk of moderate vision loss by 19%. Results of a separate study published this year showed higher intake of omega-3 fatty acids could have prevented an estimated 22% of the cases of AMD (2"The Tan Sheet" July 17, 2006, p 9). DSM will supply the supplements for AREDS2...

In Flood Of 2020 Sanitizer Launches, Unilever’s Suave Brand Tops US Category Sales

Unilever’s Suave brand led new sanitizer product sales in 2020, when hand sanitizers total sales grew 569%, according to IRI. Sales of rinseable hand-soap sales grew 64% and antiseptics 19%.

Tylenol Leads OTC Acetaminophen Sales Surge After Ibuprofen Scare During Pandemic – IRI

J&J leads sales growth in OTC pain relief and allergy categories in 2020 as its brands benefited from competing products’ problems and COVID-19’s impact of consumer habits. IRI reveals winning brands that kept a focus on maintaining health in 2020.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts